1. Home
  2. VALN vs CMPS Comparison

VALN vs CMPS Comparison

Compare VALN & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$11.30

Market Cap

875.7M

Sector

Health Care

ML Signal

N/A

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

N/A

Current Price

$7.42

Market Cap

778.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VALN
CMPS
Founded
2012
2020
Country
France
United Kingdom
Employees
N/A
166
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
875.7M
778.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
VALN
CMPS
Price
$11.30
$7.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$15.75
$27.14
AVG Volume (30 Days)
17.1K
4.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.86
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.58
N/A
Revenue Next Year
$4.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.43
$2.25
52 Week High
$12.25
$8.90

Technical Indicators

Market Signals
Indicator
VALN
CMPS
Relative Strength Index (RSI) 57.93 54.27
Support Level $8.37 $5.95
Resistance Level $12.22 $8.20
Average True Range (ATR) 0.42 0.51
MACD -0.05 -0.05
Stochastic Oscillator 59.63 43.69

Price Performance

Historical Comparison
VALN
CMPS

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: